Skip to main content
Clinical Trials/NCT05489354
NCT05489354CompletedNot Applicable

Effect of a mHealth Psycho-educational Intervention (mPEI) on Self-efficacy, Coping, and Psychological Distress Among Women Receiving Chemotherapy for Breast Cancer in Nigeria: A Randomised Controlled Trial

Chinese University of Hong Kong2 sites in 1 country126 target enrollmentStarted: September 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
126
Locations
2
Primary Endpoint
Change in self-efficacy

Study Overview

Brief Summary

The research is studying the effect of a mHealth psychoeducational intervention on self-efficacy, coping and psychological distress of Nigerian women diagnosed with breast cancer receiving chemotherapy

The study is a two-arm assessor-blinded randomised controlled trial which will be conducted in two University Teaching Hospitals in Nigeria.

Detailed Description

Aim The study aims to develop and implement a culturally adapted mHealth psychoeducational intervention (mPEI) for Nigerian women diagnosed with breast cancer receiving chemotherapy.

Objectives

  1. To evaluate the effectiveness of the programme on self-efficacy (primary outcome), coping, symptom distress, anxiety, depression, and quality of life (secondary outcomes) among women with breast cancer receiving chemotherapy
  2. To explore the participants' experiences and feelings towards the intervention.

Hypothesis

It is hypothesised that participants who receive the mPEI program, when compared with the control group at baseline and immediately after the intervention, will demonstrate:

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Masking Description

The research assistants who assess outcome data, data entry and analysis will be blinded to avoid the risk of assessor bias. The assistants will not participate in any other stage of implementing the program

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Include females who are:
  • •newly diagnosed with breast cancer within the recent three months
  • •currently receiving chemotherapy,
  • •have access to a smartphone and internet,
  • •are able to read and write in English,
  • •are cognitively capable of completing the questionnaires,
  • •consent to join the study.

Exclusion Criteria

  • •Include females:
  • •with a concurrent physical or mental illness (as these might act as a confounder)
  • •cognitively impaired

Arms & Interventions

mHealth psychoeducational intervention

Experimental

The intervention group will receive six weeks mHealth psychoeducational intervention (mPEI) delivered through a mobile application.

Intervention: mHealth psychoeducational intervention (Other)

Control Group

No Intervention

No psychoeducational intervention will be given.

Outcomes

Primary Outcomes

Change in self-efficacy

Time Frame: Pre-intervention and immediately after the six weeks intervention

Self-efficacy for coping with cancer will be measured with the Cancer Behaviour Inventory-Brief Version (CBI-B). This is a 12-item instrument measuring confidence of individuals in performing activities that show how well they are coping with the demands of cancer and their treatment. Each item will be scored on a nine-point Likert scale with '1' meaning 'not at all confident' and '9' meaning 'totally confident'. The lowest score is 12 and the highest score is 108. Higher scores indicate greater self-efficacy in coping.

Secondary Outcomes

  • Change in Depression(Pre-intervention and immediately after the six weeks intervention)
  • Change in Coping(Pre-intervention and immediately after the six weeks intervention)
  • Change in Symptom Distress(Pre-intervention and immediately after the six weeks intervention)
  • Change in Anxiety(Pre-intervention and immediately after the six weeks intervention)
  • Change in Quality of Life(Pre-intervention and immediately after the six weeks intervention)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Akingbade Oluwadamilare

Principal Investigator

Chinese University of Hong Kong

Study Sites (2)

Loading locations...

Similar Trials